Celgene: GC-LTFU-001 (Multiple Myeloma)

Purpose of this Study

We are doing this study to monitor the health and quality of life of people who participated in clinical trials for GM T cell therapies.

Who Can Participate?

Eligibility

Current or former cancer patients who received a GM T cell infusion as participants in a clinical trial sponsored by Celgene or one of Celgene's research partners.

For more information about who can join this study, please contact the study team at 919-684-9220.

What is Involved?

If you choose to join this study, you will visit our clinic for occasional check-up visits for up to 15 years.

Study Details

Full Title

GC-LTFU-001: LONG-TERM FOLLOW-UP PROTOCOL FOR SUBJECTS TREATED WITH GENE-MODIFIED T CELLS

Principal Investigator

Taewoong
Choi

Protocol Number

PRO00102299

NCT ID

NCT03435796

Phase

N/A

Enrollment Status

Open to Enrollment